SEATTLE GENETICS INC - COM (SGEN)

Historical Institutional Holders from Q1 2014 to Q4 2023

All holders as of December 31, 2023
Q4 2023
Type / Class
Equity / COM
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2023 Q4 0 $0 -$5.29M 0
2023 Q3 24.9K $5.29M -$3.06M $212.15 3
2023 Q2 41.5K $7.98M +$3.02M $192.46 4
2023 Q1 25.8K $5.22M -$5.68M $202.47 2
2022 Q4 69.9K $8.99M -$4.74M $128.51 4
2022 Q3 107K $14.6M -$3.54M $136.83 3
2022 Q2 130K $23M -$7.55M $176.95 3
2022 Q1 173K $24.8M +$4.24M $144.02 4
2021 Q4 143K $22.1M -$6.21M $154.55 5
2021 Q3 179K $30.4M -$3.8M $169.81 9
2021 Q2 198K $31.3M +$4.8M $157.86 6
2021 Q1 168K $23.3M -$84.9M $138.87 8
2020 Q4 656K $115M -$20.7B $175.14 17
2020 Q3 107M $20.9B -$9.08B $195.69 391
2020 Q2 161M $27.3B -$556M $169.92 486
2020 Q1 165M $19B +$178M $115.38 380
2019 Q4 163M $18.6B -$336M $114.26 389
2019 Q3 165M $14.1B +$497M $85.40 316
2019 Q2 161M $11.1B -$19.5M $69.21 318
2019 Q1 162M $11.9B -$115M $73.24 336
2018 Q4 164M $9.27B +$7.09M $56.66 293
2018 Q3 163M $12.6B -$127M $77.12 322
2018 Q2 165M $11B -$317K $66.39 290
2018 Q1 165M $8.66B +$990M $52.34 281
2017 Q4 147M $7.87B +$190M $53.50 293
2017 Q3 144M $7.81B +$135M $54.41 268
2017 Q2 140M $7.24B -$20.4M $51.74 299
2017 Q1 141M $8.84B +$607M $62.86 294
2016 Q4 138M $7.28B -$74M $52.77 263
2016 Q3 139M $7.52B +$53.2M $54.01 237
2016 Q2 139M $5.6B -$114M $40.41 211
2016 Q1 141M $4.96B -$11.3M $35.09 189
2015 Q4 141M $6.33B -$49.8M $44.88 229
2015 Q3 142M $5.47B +$553M $38.56 221
2015 Q2 128M $6.17B +$59M $48.40 219
2015 Q1 126M $4.46B -$46.8M $35.35 199
2014 Q4 128M $4.11B +$47.5M $32.13 211
2014 Q3 125M $4.66B -$63.5M $37.18 192
2014 Q2 127M $4.85B -$35.6M $38.25 194
2014 Q1 127M $5.81B +$69.5M $45.56 209